ZA953500B - Methods for treating neurofibromatosis - Google Patents

Methods for treating neurofibromatosis

Info

Publication number: ZA953500B
Authority: ZA; South Africa
Prior art keywords: methods; cpd; neurofibromatosis; aliphatic; formula
Prior art date: 1994-05-04

Application number

ZA953500A

Other languages

English (en)

Inventor

Stanislaw R Burzynski

Original Assignee

Burnzynski Stanislaw R

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-04

Filing date

1995-05-02

Publication date

1996-05-29

1995-05-02 Application filed by Burnzynski Stanislaw R filed Critical Burnzynski Stanislaw R

1996-05-29 Publication of ZA953500B publication Critical patent/ZA953500B/xx

Links

208000009905 Neurofibromatoses Diseases 0.000 title abstract 2
201000004931 neurofibromatosis Diseases 0.000 title abstract 2
WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 abstract 2
JFLIEFSWGNOPJJ-JTQLQIEISA-N N(2)-phenylacetyl-L-glutamine Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)CC1=CC=CC=C1 JFLIEFSWGNOPJJ-JTQLQIEISA-N 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
229960003424 phenylacetic acid Drugs 0.000 abstract 1
239000003279 phenylacetic acid Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Activated Sludge Processes (AREA)

ZA953500A 1994-05-04 1995-05-02 Methods for treating neurofibromatosis ZA953500B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/237,772 US5391575A (en)	1994-05-04	1994-05-04	Method for treating neurofibromatosis

Publications (1)

Publication Number	Publication Date
ZA953500B true ZA953500B (en)	1996-05-29

Family

ID=22895101

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA953500A ZA953500B (en)	1994-05-04	1995-05-02	Methods for treating neurofibromatosis

Country Status (7)

Country	Link
US (1)	US5391575A (de)
EP (1)	EP0680756B1 (de)
AT (1)	ATE183390T1 (de)
AU (1)	AU683145B2 (de)
DE (1)	DE69511453T2 (de)
ES (1)	ES2139774T3 (de)
ZA (1)	ZA953500B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5391575A (en) *	1994-05-04	1995-02-21	Burzynski; Stanislaw R.	Method for treating neurofibromatosis
US6127419A (en) *	1998-11-23	2000-10-03	Burzynski; Stanislaw R.	Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
US6987131B1 (en) *	2000-06-26	2006-01-17	Burzynski Stanislaw R	Phenylacetic acid compositions for treating or preventing hypercholesterolemia
WO2002018324A2 (en)	2000-08-29	2002-03-07	Nobex Corporation	Immunoregulatory compounds, derivatives thereof and their use
US8048924B2 (en) *	2001-08-29	2011-11-01	Biocon Limited	Methods and compositions employing 4-aminophenylacetic acid compounds
DK1773767T3 (en)	2004-07-07	2016-03-21	Biocon Ltd	Synthesis of azo bound in immune regulatory relations
US20060205818A1 (en) *	2005-03-08	2006-09-14	Burzynski Stanislaw R	Method for the treatment of von Hippel-Lindau (VHL) disease with phenylacetyl-derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4559325A (en) *	1981-12-15	1985-12-17	Burzynski Stanislaw R	Purified antineoplaston fractions and methods of treating neoplastic disease
US5227292A (en) *	1990-07-12	1993-07-13	University Of Utah	Neurofibromatosis type 1 gene
US5244922A (en) *	1990-09-04	1993-09-14	Burzynski Stanislaw R	Methods for treating viral infections
US5116622A (en) *	1990-09-12	1992-05-26	Burzynski Stanislaw R	Methods for treating parkinson's disease
US5391575A (en) *	1994-05-04	1995-02-21	Burzynski; Stanislaw R.	Method for treating neurofibromatosis

1994
- 1994-05-04 US US08/237,772 patent/US5391575A/en not_active Expired - Lifetime
1995
- 1995-05-02 AU AU17775/95A patent/AU683145B2/en not_active Ceased
- 1995-05-02 ZA ZA953500A patent/ZA953500B/xx unknown
- 1995-05-03 ES ES95106669T patent/ES2139774T3/es not_active Expired - Lifetime
- 1995-05-03 DE DE69511453T patent/DE69511453T2/de not_active Expired - Lifetime
- 1995-05-03 AT AT95106669T patent/ATE183390T1/de not_active IP Right Cessation
- 1995-05-03 EP EP95106669A patent/EP0680756B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU1777595A (en)	1995-11-09
ATE183390T1 (de)	1999-09-15
DE69511453D1 (de)	1999-09-23
EP0680756B1 (de)	1999-08-18
ES2139774T3 (es)	2000-02-16
DE69511453T2 (de)	1999-12-09
AU683145B2 (en)	1997-10-30
US5391575A (en)	1995-02-21
HK1016408A1 (en)	1999-10-29
EP0680756A1 (de)	1995-11-08

Similar Documents

Publication	Publication Date	Title
GB2276086A (en)	1994-09-21	Pharmaceutical products for curing tumorous diseases and process for preparing same
MA23170A1 (fr)	1994-12-31	Procede de preparation d'un nouveau compose .
MY123354A (en)	2006-05-31	4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
EP0509317A3 (en)	1993-03-03	Use of droloxifene in the treatment of bone diseases
MY106528A (en)	1995-06-30	Method of treating impotence.
GEP20002300B (en)	2000-11-25	Purified Forms of Dnase, Method for Its Production, Pharmaceutical Composition and Use Thereof
ZA911496B (en)	1991-12-24	Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
GR3022519T3 (en)	1997-05-31	Use of ketoconazole and a retinoid for the treatment of acne vulgaris
ATE137965T1 (de)	1996-06-15	Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
AU8091787A (en)	1988-05-12	The use of paroxetine to treat pain
ATE172117T1 (de)	1998-10-15	Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
ZA953500B (en)	1996-05-29	Methods for treating neurofibromatosis
MY104006A (en)	1993-10-30	4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases.
DE69800859D1 (de)	2001-07-05	Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
HUT61199A (en)	1992-12-28	Process for producing pharmaceutical compositions suitable for treating hyperlipidaemia and/or atherosclerosis
GR3021813T3 (en)	1997-02-28	Method of treating alopecia
ITRM910730A1 (it)	1993-03-30	Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
ZA934021B (en)	1995-01-16	Treatment of bovine mastitis
ATE204476T1 (de)	2001-09-15	Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
GR3022935T3 (en)	1997-06-30	Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients
Azizbekov et al.	1990	Effects of magnetic induction on bacterial wound contamination in children.
CY2019A (en)	1998-02-20	The use of bmy 14802 in the treatment of anxiety in benzodiazepine-withdrawn patients